In summary, we demonstrate the potential protective effects of IL-10-modulated adipose-derived stromal cells in decreasing diabetes-induced DPP4 activity, insulin resistance, and liver gluconeogenesis (Figure 8). Here, IL10 is linked to diabetes mellitus.